Investigating biomarkers of Staphylococcus aureus bacteremia in patients - School of Pharmacy

The Centers for Disease Control identifies methicillin-resistant S. aureus (MRSA) as a serious health threat with greater than 100,000 invasive infections and 20,000 patient deaths annually in the United States. Despite recent advancements in available treatment options for methicillin-sensitive S.

Antibiotics, Free Full-Text

View of Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans

Critical Care Pharmacist Advancement — Andrea Sikora

Pathogens, Free Full-Text

Implementing a hospital-wide protocol for Staphylococcus aureus bacteremia

Methicillin-resistant Staphylococcus aureus: novel treatment approach breakthroughs, Bulletin of the National Research Centre

Estimation of Activity of CD14 Biomarker in Iraqi Burn Patients

Antimicrobial resistance - Wikipedia

Staphylococcus aureus bacteraemia: does duration matter? - The Lancet Infectious Diseases

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Research Week 2020 – Department of Pediatrics – UW–Madison